No Photo Available

Last Update

2017-03-23T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Timothy Franson?

Dr. Timothy R. Franson

Chief Medical Officer

YourEncore Inc

Direct Phone: (317) ***-****       

Email: t***@***.com

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

YourEncore Inc

20 N. Meridian Street Suite 800

Indianapolis, Indiana 46204

United States

Company Description

YourEncore's mission is to put experience to work. We offer clients the opportunity to tap into the most accomplished and experienced community of experts in the world. We offer experts the opportunity to use their experience to make a lasting difference. ... more

Find other employees at this company (347)

Background Information

Employment History

Global Regulatory Affairs Practice

FaegreBD Consulting

President

U.S. Pharmacopeia

President

US Pharmacopeial Convention

Vice President of Global Regulatory Affairs and Patient Safety

Eli Lilly and Company

Founder and President

Franson PharmAdvisors LLC

Affiliations

Board Member
Cidara Therapeutics, Inc.

Board Member
Paratek Pharmaceuticals , Inc.

Board of Trustees
Food and Drug Administration

Board Member
Critical Path Institute

Member
AAMC-PhRMA Clinical Trials Forum

Board Member
Center for Medicine in the Public Interest

Board Member
Villages Inc

Board Member
Myriad Genetic Laboratories , Inc.

Member of the Governor's Task Force On AIDS
Medical College of Wisconsin

Chair of the Clinical Steering Committee
Manufacturing.net

Committee Staff Work Group
PhRMA companies

Member of the Regulatory Advisory Board
CMR International

Chair of the Clinical Steering Committee
Pharmaceutical Research

Member
Governance Committee

Fellow
American College of Physicians

Senior Advisor
Food and Drug Administration

Board Member
Little Red Door Cancer Agency Inc

Senior Advisor
Bentleyville Borough

Fellow
Infectious Diseases Society of America

Senior Fellow
Center for Medicine in the Public Interest

Senior Advisor
CDC & NIH

Board Member
National Patient Safety Foundation

Board of Trustees
Xavier University

Board Member
Indiana State Museum

Member
American Society for Microbiology

Fellow
The American College

Member
American Federation for Clinical Research

Committees
industry-FDA

Board Member
College of Pharmacy Dean's Advisory Board for Auburn University

Board Member
Myrexis Pharmaceuticals

Education

American Board of Internal Medicine

B.S.

Pharmacy

Drake University

M.D.

M.D.

Galesburg High School

M.D. degree

University of Illinois

M.S. Chief Medical Officer

undergraduate degree

Pharmacy

University of Illinois

Web References (90 Total References)


Committee Composition - Paratek Pharmaceuticals

investor.paratekpharma.com [cached]

Timothy Franson, M.D.,

...
Timothy Franson, M.D., Director
Timothy Franson, M.D., has served on our Board of Directors since July 2015. Since April 2014, Dr. Franson has been the Chief Medical Officer for YourEncore, a consultancy that helps global life sciences and consumer health companies accelerate new product pipelines and bring safer, more effective products to consumers. From 2009 to 2014, he was a Principal in FaegreBD Consulting's health and biosciences sector where he led the firm's global regulatory affairs practice. Until 20... 


Board of Directors - Paratek Pharmaceuticals

investor.paratekpharma.com [cached]

Timothy Franson, M.D., Director

Timothy Franson, M.D., has served on our Board of Directors since July 2015. Since April 2014, Dr. Franson has been the Chief Medical Officer for YourEncore, a consultancy that helps global life sciences and consumer health companies accelerate new product pipelines and bring safer, more effective products to consumers. From 2009 to 2014, he was a Principal in FaegreBD Consulting's health and biosciences sector where he led the firm's global regulatory affairs practice. Until 2008, Dr. Franson was Vice President of Global Regulatory Affairs at Lilly Research Laboratories (Eli Lilly and Company). Dr. Franson has been directly involved in dozens of successful major regulatory approvals, and he has extensive clinical and regulatory experience in all pre- and post-approval phases of pharmaceutical development. He has co-chaired working groups for several industry initiatives, including the joint Food and Drug Administration, or FDA,-industry working group addressing clinical aspects of the FDA Modernization Act of 1997. Dr. Franson served as the President of the US Pharmacopeia Convention (USP), which establishes drug quality standards enforced by regulators such as FDA, from 2010 to 2015, and continues to serve on the organization's Board of Trustees as immediate Past President. In addition, Dr. Franson serves on the board of directors for Cidara Therapeutics and recently joined the board of directors for the Critical Path Institute, which collaborates with FDA and industry in innovation advances. He served on the board of directors for Myrexis (formerly Myriad) Pharmaceuticals (NASDAQ: MYRX) from 2010 to 2013. Dr. Franson received his medical degree from the University of Illinois College of Medicine.


Paratek Board of Directors

paratekpharma.com [cached]

Timothy Franson, M.D.

Director
Timothy R. Franson, M.D. has served on our Board of Directors since July 2015. Since April 2014, Dr. Franson has been the Chief Medical Officer for YourEncore, a consultancy that helps global life sciences and consumer health companies accelerate new product pipelines and bring safer, more effective products to consumers. From 2009 to 2014, he was a Principal in FaegreBD Consulting's health and biosciences sector where he led the firm's global regulatory affairs practice. Until 2008, Dr. Franson was Vice President of Global Regulatory Affairs at Lilly Research Laboratories (Eli Lilly and Company). Dr. Franson has been directly involved in dozens of successful major regulatory approvals, and he has extensive clinical and regulatory experience in all pre- and post-approval phases of pharmaceutical development. He has co-chaired working groups for several industry initiatives, including the joint Food and Drug Administration, or FDA,-industry working group addressing clinical aspects of the FDA Modernization Act of 1997. Dr. Franson served as the President of the US Pharmacopeia Convention (USP), which establishes drug quality standards enforced by regulators such as FDA, from 2010 to 2015, and continues to serve on the organization's Board of Trustees as immediate Past President. In addition, Dr. Franson serves on the board of directors for Cidara Therapeutics and recently joined the board of directors for the Critical Path Institute, which collaborates with FDA and industry in innovation advances. He served on the board of directors for Myrexis (formerly Myriad) Pharmaceuticals (NASDAQ: MYRX) from 2010 to 2013. Dr. Franson received his medical degree from the University of Illinois College of Medicine.


Board of Directors | Cidara Therapeutics

www.cidara.com [cached]

Timothy Franson, M.D.

Dr. Franson has served as the chief medical officer of YourEncore, an advisory firm focused on global life sciences and consumer health companies, since May 2014. From 2009 until May 2014, he was a principal of FaegreBD Consulting, a clinical and regulatory pharmaceutical development consulting firm, and currently maintains a relationship with FaegreBD through its strategic alliance with YourEncore. From 2008 until 2009, Dr. Franson served as the founder and president of Franson PharmaAdvisors LLC, a clinical and regulatory pharmaceutical development consulting firm. Prior to assuming these roles, Dr. Franson was vice president of Global Regulatory Affairs at Lilly Research Laboratories, a part of Eli Lilly and Company, which he joined in 1986. Dr. Franson is integrally involved in global public health initiatives through the US Pharmacopeial Convention (USP), currently serving as the president of this organization and on the executive committee of the USP Board of Trustees. He serves on the Board of Directors of Paratek Pharmaceuticals and the Critical Path Institute, which collaborates with FDA and industry in innovation advances. Dr. Franson has authored more than 50 articles in the fields of infectious disease, epidemiology, pharmacoeconomics, and antibiotic utilization. He holds a B.S. in pharmacy from Drake University and an M.D. from the University of Illinois College of Medicine. He is board certified in Internal Medicine and Infectious Diseases.


People | Critical Path Institute

c-path.org [cached]

Timothy R. Franson, MD

...
Timothy R. Franson, MD
Dr. Timothy R. Franson is Chief Medical Officer for YourEncore, responsible for the strategy and development of their clinical, regulatory, pharmacovigilance, and quality program offerings. He has extensive clinical and regulatory experience in all pre- and post-approval phases of pharmaceutical development relating to interactions with the FDA for policy and product issues, as well as with global regulators. He also serves as the current president of the U.S. Pharmacopeial Convention and on the Executive Committee of its Board of Trustees.
Dr. Franson was the founder and president of Franson PharmAdvisors LLC, a clinical and regulatory pharmaceutical development consulting firm that merged with FaegreBD Consulting. Prior to this, Dr. Franson was Vice President of Global Regulatory Affairs at Lilly Research Laboratories (Eli Lilly and Company) after serving as their Vice President of Clinical Research and Regulatory Affairs-U.S.
Dr. Franson was co-chair of the joint FDA-industry working group addressing clinical aspects of the FDA Modernization Act of 1997, including the Prescription Drug User Fee Act (PDUFA) renewal. He also co-chaired an FDA-industry safety interventions working group, was a member of the AAMC-PhRMA Clinical Trials Forum and of the Regulatory Advisory Board for the Centre for Medicines Research International. He recently served on the NIH-NCATS Treatment of Rare and Neglected Diseases (TRND) review panel, and currently serves as President of the United States Pharmacopeial Convention.
Dr. Franson has authored more than 50 articles in the fields of infectious disease, epidemiology, pharmacoeconomics, and antibiotic utilization, as well as four book chapters relating to innovation policy topics. He also served as a member of the Board of Directors for Myrexis (formerly Myriad) Pharmaceuticals from 2010 to 2013.
Dr. Franson received his BS in Pharmacy from Drake University, his MD from the University of Illinois College of Medicine, Internal Medicine training from the University of Iowa, and completed a Fellowship in Infectious Diseases and Epidemiology at the Medical College of Wisconsin.

Similar Profiles

Other People with this Name

Other people with the name Franson

Stephen Franson
The Remarkable Practice Academy

Jared Franson
Brigham Young University

Debbie Franson
Kinzie Real Estate Group LLC

Elizabeth Franson
Wells Fargo & Company

Susan Franson
Delta Air Lines Inc.

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory